Nigericin sodium

For research use only. Not for therapeutic Use.

  • CAT Number: I008178
  • CAS Number: 28380-24-7
  • Molecular Formula: C40H68O11
  • Molecular Weight: 724.96
  • Purity: ≥95%
Inquiry Now
Nigericin sodium is a potassium ionophore and a selective antibiotic compound that facilitates the exchange of potassium and hydrogen ions across cellular membranes. It has been primarily used in scientific research to disrupt cellular ion gradients, leading to alterations in pH and membrane potential. Nigericin sodium is known for its ability to induce ion imbalances, making it useful in studying cellular processes such as membrane transport, mitochondrial function, and apoptosis. It also has potential applications in immunology and cancer research.

Catalog Number I008178
CAS Number 28380-24-7
Synonyms

Antibiotic K178, Antibiotic X464, Azalomycin M, Helexin C, Polyetherin A;sodium (R)-2-((2R,3S,6R)-6-(((2S,4R,5R,7R,9R,10R)-2-((2S,2/’R,3/’S,5R,5/’R)-5/’-((2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyltetrahydro-2H-pyran-2-yl)-2,3/’-dimethyloc

Molecular Formula C40H68O11
Purity ≥95%
Target Immunology/Inflammation
Solubility Soluble in DMSO, not in water
Storage 0 - 4 °C for short term, or -20 °C for long term
IUPAC Name (2R)-2-[(2R,3S,6R)-6-[[(2S,4R,5R,6R,7R,9R)-2-[(2R,5S)-5-[(2R,3S,5R)-5-[(2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]-5-methyloxolan-2-yl]-7-methoxy-2,4,6-trimethyl-1,10-dioxaspiro[4.5]decan-9-yl]methyl]-3-methyloxan-2-yl]propanoic acid
InChI 1S/C40H68O11/c1-21-11-12-28(46-33(21)26(6)36(42)43)17-29-18-30(45-10)27(7)40(48-29)25(5)19-38(9,51-40)32-13-14-37(8,49-32)35-23(3)16-31(47-35)34-22(2)15-24(4)39(44,20-41)50-34/h21-35,41,44H,11-20H2,1-10H3,(H,42,43)/t21-,22-,23-,24+,25+,26+,27+,28+,29+,30+,31+,32+,33+,34-,35+,37-,38-,39-,40+/m0/s1
InChIKey DANUORFCFTYTSZ-SJSJOXFOSA-N
SMILES C[C@H]1CC[C@@H](O[C@H]1[C@@H](C)C(=O)O)C[C@@H]2C[C@H]([C@H]([C@@]3(O2)[C@@H](C[C@@](O3)(C)[C@H]4CC[C@@](O4)(C)[C@H]5[C@H](C[C@@H](O5)[C@@H]6[C@H](C[C@H]([C@@](O6)(CO)O)C)C)C)C)C)OC

Request a Quote